Digene Looks Forward To Piggybacking On Merck’s HPV Vaccine Ad Campaign

Digene expects a big boost this summer when pharmaceutical giant Merck begins heavily promoting its human papillomavirus (HPV) vaccineGardasil, expected to clear FDA in early June

More from Archive

More from Medtech Insight